Review

flutter® opep device 820 (Axcan Scandipharm)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Axcan Scandipharm flutter® opep device 820
Flutter® Opep Device 820, supplied by Axcan Scandipharm, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flutter+device/mucus+clearance+device+flutter/us12194236-449-37-42
Average 90 stars, based on 1 article reviews

flutter® opep device 820 - by Bioz Stars, 2026-09

90/100 stars

Images

Produced:

Article Title: The Short-Term Effect of Breathing Tasks Via an Incentive Spirometer on Lung Function Compared With Autogenic Drainage in Subjects With Cystic Fibrosis.
Article Snippet: .. With the Flutter device (Axcan Scandipharm, Birmingham, Alabama), the PEP and cyclic oscillation (airway vibration) are produced by lifting a gravity-dependent ball and sustaining it in the air. .. The Acapella device (Smiths Medical, Watford, United Kingdom) comes in 3 models: low flow ( 15 L/min), high flow ( 15 L/min), and a dial that sets expiratory resistance.

other:

Article Title: The Flutter Device versus the PEP Mask in the Treatment of Adults with Cystic Fibrosis
Article Snippet: Purpose: The purpose of this study was to compare the effectiveness of the Flutter device (Axcan Scandipharm Inc., Birmingham, AL) with that of the PEP Mask (Astra Tech AB, Molndal, Sweden) in the treatment of adults with cystic fibrosis (CF).. Methods: Forty-two adults (mean age 29 F 8.4 years) were recruited from the Adult Cystic Fibrosis Program at St. Michael’s Hospital and were randomly assigned to airway clearance treatment with either the Flutter device or the PEP Mask.. Pulmonary function tests, the Quality of WellBeing Scale (QWB), and the Chronic Respiratory Disease Questionnaire (CRQ) were administered 1 month postrecruitment and every 3 months thereafter for 13 months.

Article Title: The flutter device and expiratory pressures.
Article Snippet: Cardiorespiratory physical therapy uses noninvasive interventions, including exercise and mobilization, body positioning, breathing control and coughing maneuvers, relaxation and energy conservation, and airway clearance techniques.. The goal is to maximize well-being and minimize disability in individuals with cardiac or respiratory conditions.. In individuals with cystic fibrosis, the goals of cardiorespiratory physical therapy include promotion of effective alveolar ventilation and adequate oxygenation, mobilization and removal of secretions, maintenance of chest wall mobility, and enhancement of exercise tolerance.

Sequencing:

Article Title: Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis
Article Snippet: .. Interventions , 2 interventions: 21 participants were randomised to each group. 1. PEP treatment ‐ pressure 10 ‐ 20 cm H2O using an Astra Meditec PEP mask; seated participants breathed 10 ‐ 15 times through the mask, followed by huffing, coughing and relaxed breathing, this was repeated 5 ‐ 6 times, over a 20‐minute session, twice daily; 2. Oscillating PEP ‐ participants exhaled through the flutter device (Axcan Scandipharm) which was angled to maximise the sensation of vibration in the chest. In sitting, participants inhaled deeply through the nose, followed by a breath hold for 2 ‐ 3 seconds, and exhalation through the device. After 5 ‐ 10 breaths, participants increased the TV and speed of exhalation through the device, to precipitate coughing and expectoration. This sequence was repeated "until clear" or for approximately 20 minutes, twice daily. , . ..